Literature DB >> 25923780

Rivaroxaban use in patients with antiphospholipid syndrome and previous venous thromboembolism.

Savino Sciascia, Sciascia Savino1, Karen Breen, Beverley J Hunt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25923780     DOI: 10.1097/MBC.0000000000000247

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


× No keyword cloud information.
  13 in total

Review 1.  Anticoagulating patients with high-risk acquired thrombophilias.

Authors:  Leslie Skeith
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Direct oral anticoagulants in hypercoagulable states.

Authors:  Paul R Kunk; Jacqueline Brown; Melissa McShane; Surabhi Palkimas; B Gail Macik
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

Review 3.  Recurrent Thrombosis in Patients with Antiphospholipid Syndrome Receiving Newer Oral Anticoagulants: A Case Report and Review of Literature.

Authors:  Akanksha Joshi; Jason Hong; Chokkalingam Siva
Journal:  Clin Med Res       Date:  2017-06

Review 4.  Diagnosis and management of the antiphospholipid syndrome.

Authors:  Shruti Chaturvedi; Keith R McCrae
Journal:  Blood Rev       Date:  2017-07-30       Impact factor: 8.250

Review 5.  Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature.

Authors:  Virginie Dufrost; Jessie Risse; Stéphane Zuily; Denis Wahl
Journal:  Curr Rheumatol Rep       Date:  2016-12       Impact factor: 4.592

6.  Role of Novel Oral Anticoagulants in the Treatment of Antiphospholipid Syndrome.

Authors:  C Whitney White; Angela R Thomason; Katie Boyd
Journal:  Hosp Pharm       Date:  2016-10

7.  Thrombotic events in patients with antiphospholipid syndrome treated with rivaroxaban: a series of eight cases.

Authors:  Flavio Signorelli; Felipe Nogueira; Vinicius Domingues; Henrique Ataide Mariz; Roger A Levy
Journal:  Clin Rheumatol       Date:  2015-07-30       Impact factor: 2.980

8.  Comparison of the Therapeutic Effects of Rivaroxaban Versus Warfarin in Antiphospholipid Syndrome: A Systematic Review.

Authors:  Mandana Khodashahi; Zahra Rezaieyazdi; Maryam Sahebari
Journal:  Arch Rheumatol       Date:  2019-12-12       Impact factor: 1.472

9.  Coexistence of Antiphospholipid Syndrome and Heparin-Induced Thrombocytopenia in a Patient with Recurrent Venous Thromboembolism.

Authors:  Samuel Adediran; Nicole Agostino
Journal:  Case Rep Hematol       Date:  2017-04-26

10.  Rivaroxaban - a safe therapeutic option in patients with antiphospholipid syndrome? Our experience in 23 cases.

Authors:  Ewa Haładyj; Marzena Olesińska
Journal:  Reumatologia       Date:  2016-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.